News and Latest Activity

January 8th 2026

ImmunoKey Appoints World-Leading Cell Therapy Experts to Scientific Advisory Board

June 2nd 2025

ImmunoKey Awarded $225,000 ScaleReady G-Rex® Grant to Advance CAR T-Cell Manufacturing

April 28th 2025

ImmunoKey announces a strategic collaboration with OxTium, an AI-driven technology company, to Advance target discovery for CAR T-Cell Therapies

April 3rd 2025

ImmunoKey Selected for Bruntwood Life Science Accelerator 2025 Cohort